Wendall Wierenga - Feb 6, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Wierenga
Stock symbol
CYTK
Transactions as of
Feb 6, 2023
Transactions value $
-$267,960
Form type
4
Date filed
2/8/2023, 03:01 PM
Previous filing
Jan 4, 2023
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $47K +7K +55.85% $6.72* 19.5K Feb 6, 2023 Direct F1
transaction CYTK Common Stock Sale -$315K -7K -35.84% $45.00 12.5K Feb 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7K -53.76% $0.00 6.02K Feb 6, 2023 Common Stock 7K $6.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 8, 2022.